Telomerase activity in human renal cell carcinoma

BJU International

Volumn 83, Issue 6, 1999, Pages 693-697

  Sugimura, K ^a   Yoshida, N ^a   Hisatomi, H ^b   Nakatani, T ^a   Ikemoto, S ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SRL INC   (Japan)

Author keywords

Primary cell culture; Prognostic test; Renal cell carcinoma; Telomerase

Indexed keywords

TELOMERASE;

ARTICLE; CANCER GRADING; CELL CULTURE; CELL IMMORTALIZATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDRONEPHROSIS; KIDNEY CARCINOMA; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL;

CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; NEOPLASM PROTEINS; PROGNOSIS; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0032939977     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00992.x     Document Type: Article

References (14)

1. 1 Moyzis RK, Buckingham JM, Cram LS et al. A highly conserved repetitive DNA sequence, (TTAGGG) n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622-6
2. 2 Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblasts. Nature 1990; 345: 458-60
3. 3 Feng J, Funk WD, Wang S et al. The RNA component of human telomerase. Science 1995; 269: 1236-41
4. 4 Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-5
5. 5 Counter CM, Gupta J, Harley CB, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315-20
6. 6 Mehle C, Ljungberg B, Roos G. Telomerase shortening in renal cell carcinoma. Cancer Res 1994; 54: 236-41
7. 7 Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene 1996; 13: 161-6
8. 8 Kinoshita H, Ogawa O, Mitsumori K, Kakehi Y, Terachi T, Yoshida O. Low frequency of positive telomerase activity in a chromophobe subtype of renal cell carcinoma. J Urol 1998; 159: 245-51
9. 9 Ohyashiki JH, Ohyashiki K, Toyama K, Shay JW. A nonradioactive, fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activity. Trends Genet 1996; 12: 395-6
10. 10 Holt SE, Norton JC, Wright WE, Shay JW. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods Cell Sci 1996; 18: 237-48
11. 11 Hiyama E, Yokoyama T, Tatsumoto N et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258-62
12. 12 Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Med 1995; 1: 249-55
13. 13 Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med 1997; 3: 1271-4
14. 14 Nakamura TM, Morin GB, Chapman KB et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-9